Sirona Dental Systems (SIRO)

69.61 +0.00  +0.00%  May 22, 2:43PM
Add to Watchlists Create an Alert

Sirona Dental Systems R&D Expense Quarterly:

14.10M for Dec. 31, 2012
View Full Chart

Sirona Dental Systems R&D Expense Quarterly Chart

    Sirona Dental Systems Historical R&D Expense Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 2   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    Dec. 31, 2012 14.10M
    Sept. 30, 2012 12.61M
    June 30, 2012 13.09M
    March 31, 2012 13.64M
    Dec. 31, 2011 13.29M
    Sept. 30, 2011 13.48M
    June 30, 2011 14.39M
    March 31, 2011 14.14M
    Dec. 31, 2010 13.51M
    Sept. 30, 2010 11.56M
    June 30, 2010 11.65M
    March 31, 2010 11.69M
    Dec. 31, 2009 11.46M
    Sept. 30, 2009 9.633M
    June 30, 2009 9.897M
    March 31, 2009 10.04M
    Dec. 31, 2008 11.06M
    Sept. 30, 2008 11.24M
    June 30, 2008 11.83M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
       
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro
    Dec. 31, 2000 Go Pro
    Sept. 30, 2000 Go Pro

    About R&D Expense

    R&D expenses are a line item from many companies' income statements.

    R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.

    Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.

    An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
    Learn More

    Get data for

    SIRO R&D Expense Quarterly Benchmarks

    Companies
    Patterson Companies
    DENTSPLY International
    Henry Schein

    SIRO R&D Expense Quarterly Rankings

    Overall 94th percentile
    468 of 8005
    Sector 83rd percentile
    115 of 686 in Healthcare
    Industry 81st percentile
    14 of 74 in Medical Instruments & Supplies

    SIRO R&D Expense Quarterly Range, Past 5 Years

    Minimum 9.633M Sep 2009
    Maximum 14.39M Jun 2011
    Average 12.23M